Podcasts about CSO

18-year-olds wake up fresh because their repair system still works. This episode shows you how stem cell decline quietly drives fatigue, inflammation, and faster aging, and how fasting can reactivate your body's natural ability to repair itself without expensive stem cell procedures. Grab a generous 30% discount on any STEMREGEN product with: http://stemregen.co/dave30 Dave Asprey sits down with Christian Drapeau, a neuroscientist trained at McGill University and a leading researcher in stem cell science. Christian pioneered a therapeutic approach called Endogenous Stem Cell Mobilization, authored the bestselling book Cracking the Stem Cell Code, and developed the concept of stem cell enhancement. He is the Founder and CSO of STEMREGEN, where his work focuses on helping the body release and use its own stem cells more effectively. Together, they break down why many injected stem cells never survive long enough to help, how the lungs trap a large percentage of IV stem cells, and why releasing your own stem cells into arterial circulation changes the outcome. They explore stem cell decline as a core driver of aging, tissue degeneration, and chronic inflammation, and explain why fasting is currently the only intervention shown to rejuvenate stem cells through autophagy. You'll hear why a three-day fast has measurable effects on bone marrow aging, how stem cells act as signaling molecules that coordinate repair across the body, and why mitochondria play a massive and underappreciated role in stem cell renewal and tissue regeneration. The conversation also covers scar tissue, fibrosis, recovery from injury, and why healing quality matters just as much as healing speed. You'll Learn: • Why stem cell decline, not simple wear and tear, drives aging • How fasting supports stem cell rejuvenation through autophagy • Why many injected stem cells die in the lungs before helping tissue • How releasing your own stem cells differs from IV stem cell therapy • Why mitochondria are central to stem cell function and repair • How scar tissue and fibrosis form when repair fails • Why recovery quality determines long-term resilience and longevity Dave Asprey is a four time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade is the top podcast for people who want to take control of their biology, extend their longevity, and optimize every system in the body and mind. Each episode features cutting edge insights in health, performance, neuroscience, supplements, nutrition, hacking, emotional intelligence, and conscious living. Thank you to our sponsors! • TRU KAVA | Go to https://trukava.com/ and use code DAVE10 for 10% off. • Generation Lab | Go to http://generationlab.com/, use code DAVE20 for $20 off, and see what your body's really doing behind the surface. • Puori | Use code DAVE at https://puori.com/DAVE to get 32% off your Puori Fish Oil when you start a subscription. • Screenfit | Get your at-home eye training program for 40% off using code DAVE at https://www.screenfit.com/dave. Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights in health, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: stem cell longevity, fasting stem cell rejuvenation, three day fast science, biohacking stem cells, endogenous stem cell mobilization, stem cell decline aging, autophagy fasting longevity, mitochondria stem cells, tissue repair aging, inflammation and aging science, functional medicine longevity podcast, human performance longevity, anti-aging fasting protocol, metabolism and aging, ketosis fasting science, supplements longevity debate, Dave Asprey longevity, Christian Drapeau stem cells, biohacking podcast longevity Resources: • Learn More About Everything STEMREGEN at: http://stemregen.co/dave30 • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Join My Low-Oxalate 30-Day Challenge: https://daveasprey.com/2026-low-ox-reset/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com Timestamps: 0:00 — Trailer 1:20 — Stem Cell Basics & IV vs Release 7:41 — Bone Marrow Conversion & Fasting 11:01 — Stem Cell Decline vs Exhaustion 12:39 — Releasing Stem Cells 14:01 — Stem Cells as Signaling Molecules 18:13 — Stacking Interventions 23:31 — Dosing & Duration 40:42 — Daily Repair & Deficits 48:20 — Resilience & Testing 53:17 — Inflammation as Signal 57:45 — Closing See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this podcast episode, Dr. Jonathan H. Westover talks with Ashlie Marshall about the importance of empathetic leadership in the modern world of work. Ashlie Marshall is a results-driven Chief Strategy Officer at Tier Level who transforms digital marketing challenges into growth opportunities. Since joining the company in 2018, she rapidly advanced from Account Manager to CSO through her exceptional ability to build client relationships and deliver measurable business outcomes. In her current role, Ashlie collaborates with business owners to develop customized digital marketing strategies that align with their organizational culture while driving revenue growth. She simultaneously leads Tier Level's strategic initiatives, establishing infrastructure that positions the company as an industry leader. Ashlie's professional journey reflects her determination to overcome obstacles and help others succeed. Her balanced perspective as a strategist, marketing professional, team leader, wife, and mother informs her holistic approach to business challenges. Through authentic partnerships and forward-thinking leadership, Ashlie continues to create meaningful impact for clients and colleagues alike. Check out all of the podcasts in the HCI Podcast Network!

Today on the show, we have Charles Rosenblatt, CEO of Butter Payments, providing ML AI-driven payment recovery for subscription merchants and recurring payments. Previously, Charles was CSO of Payoneer, CRO at Velo Payments, and ran treasury at D.E. Shaw during the late 90s—where managing a financial crisis taught him that outside factors can derail even the best strategies and smartest teams. In this episode, we uncover why the 14-day dunning period is an arbitrary standard that shouldn't exist—and how decoupling dunning strategy from product access unlocks smarter business decisions. Charles shares how Butter analyzes 128 variables across billions of transactions to predict payment recovery within 10 seconds, allowing companies to shut off high-cost AI users immediately when recovery is unlikely, while keeping loyal customers active when payments will clear. We explore why involuntary churn creates dangerous false signals: 30% of customers leaving might actually want to stay but have expired cards or temporary payment issues. This can lead product teams to catastrophic decisions—like Coca-Cola changing their formula when the real problem was payment infrastructure, not product-market fit. The lesson: understand what's within your control versus what's not before making strategic pivots. We also discuss how Capital One shifted their best people from acquisition to retention after realizing they were churning the equivalent of the 7th largest credit card company every year—because spending $20 to save a $500 NPV customer beats spending $300 to acquire a new one who might churn anyway. Finally, we dig into payment recovery ethics and strategy: why Butter refuses "forced payments" that drive customer accounts negative, how different card types (Amex vs. debit vs. prepaid) require completely different retry logic, and why competitors who inflate recovery promises by 100% damage trust across the industry.As always, I'd love to hear from you. You can email me directly at andrew@churn.fm, and don't forget to follow us on X.Churn FM is sponsored by Vitally, the all-in-one Customer Success Platform.

Comparing and contrasting Disney's “Something Wicked This Way Comes” with the novel by Ray Bradbury.  This podcast contains certain copyrighted works that were not specifically authorized to be used by the copyright holder(s), but which we believe in good faith are protected by federal law and the fair use doctrine (Section 107 of the Copyright Act). If […] The post CSO 21b – Something Wicked This Way Comes Part 2 first appeared on Cinema Story Origins Podcast.

Comparing and contrasting Disney's “Something Wicked This Way Comes” with the novel by Ray Bradbury.  This podcast contains certain copyrighted works that were not specifically authorized to be used by the copyright holder(s), but which we believe in good faith are protected by federal law and the fair use doctrine (Section 107 of the Copyright Act). If […] The post CSO 21a – Something Wicked This Way Comes Part 1 first appeared on Cinema Story Origins Podcast.

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with 20+ CEO/c-suite leaders from the CDMO space, who discuss the big headwinds for the pharmaceutical and biotechnology space for 2026.   Show features: Christiane Bardroff, Chief Operating Officer (COO) at Rentschler Biopharma SE Philip Macnabb, Chief Executive Officer at Curia Kaan-Fabian Kekec, Partner at Simon-Kucher‘s Healthcare & Life Sciences division Dirk T. Lange , Chief Executive Officer at Pyramid Pharma Services Bruce Thompson, CTO at Kincell Bio Bill Vincent, Biotech Entrepreneur, CEO, Board Member Derek Hennecke - founder, investor, board member Matthew Bio, CSO at Cambrex & President, Snapdragon Chemistry Stephen Dilly, CEO at Sonoma Biotherapeutics, Stephen Dilly, CEO at Sonoma Biotherapeutics, Bill Humphries, Chief Executive Officer at Medpharm Elisabeth Stampa, CEO at Medichem SL Kerstin Dolph, SVP of Manufacturing at Charles River Labs Eric Edwards, Chief Executive Officer at Phlow-USA Peter DeYoung, CEO at Piramal Pharma Ian Tzeng, Managing Director at L.E.K. Consulting Adam Siebert, Managing Director at L.E.K. Consulting J.D. Mowery, President CDMO Division Bora Pharmaceuticals Peter Belden President, US, Tjoapack Nick Fortin, CEO CODIS Molecule to Market is also sponsored by Bora Pharmaceuticals and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

Aging does NOT have to keep us down. In this episode, join me for a feel-good conversation with the CSO of Berkeley Life– Cathy Eason– all about midlife, hormones, and protecting your heart as you age stronger.  Together, we explore how boosting mitochondrial health and blood flow can radically improve energy, resilience, and overall vitality.  Kathy shares actionable lifestyle strategies to increase nitric oxide production for easing symptoms, plus offers supportive solutions when you need a little extra help during perimenopause and menopause.  We also talk about targeted supplements that support heart health, circulation, mood, sleep, stress response, and neurotransmitters—all in one place.  Tune in here to boost your blood flow, help your heart, and thrive through midlife and beyond!Cathy Eason Cathy Eason is the Chief Science Officer at Berkeley Life. She has over 20 years of experience as a functional medicine focused nutritionist, women's health educator, speaker, and wellness strategist specializing in midlife health. She bridges cutting-edge science with practical solutions for perimenopause and menopause, focusing on cardiovascular health, nitric oxide biochemistry, and whole-body resilience. Cathy's known for translating complex physiology into empowering insights that help women thrive through midlife and beyond. IN THIS EPISODE Cathy's perimenopause journey & her non-negotiables for thriving through it  The benefits of regulating your nervous system How insulin resistance impacts perimenopause symptoms  Why we need to talk more about blood flow for whole body wellness  The benefit of nitric oxide in perimenopause and menopause  How to best support yourself through midlife hormone shifts  The positive impact of Berkeley Life supplementation  How to get 15% off your Berkeley Life Nitric Oxide supplement!  QUOTES“We're seeing those perimenopausal signs come on earlier and earlier, and unfortunately, I think it's happening to younger and younger women too.” “We need to stop apologizing for what's happening to us. Recognize that we can be proactive about our health, but we also don't have to apologize for sweating during a meeting, or being a little cranky in the morning because we didn't get good sleep the night before.” “That's the biggest thing I feel by taking the Berkeley Life supplementation— I have consistent energy every day and I wake up motivated for the day ahead of me. And to me that equates to being energized, to having mitochondrial energy to get me through the day.” RESOURCES MENTIONED Order my new book: The Perimenopause Revolution https://peri-revolution.com/ Order your Berkeley Life Nitric Oxide Support Supplement HERE! https://berkeleylife.pxf.io/Vxvdja Use Code: THRIVE15 for 15% off! Berkeley Life Website Berkeley Life on Instagram Berkeley Life on Facebook Berkeley Life LinkedIn Berkeley Life on YouTube RELATED EPISODES  675: Feeling Off After 40? The Surprising Vitality Molecule to Reignite Your Energy, Libido & Confidence with Cathy Eason 711: Estrogen, Inflammation, and Your Heart Health: What Every Woman Needs to Know with Dr. Sanjay Bhojraj 704: Hormone Intelligence for Women in Midlife: How to Thrive Through Perimenopause with Dr. Aviva Romm 693: Tired All the Time? It Might Be Hidden Problems With Your Mitochondria with Siobhan Mitchell

Get your pencils and notebooks out because it is time to get wiser about soccer together! Bobby Warshaw (Bloom Sports) takes David & Matt through the exercise of planning a winning MLS roster. He asks them the same questions he asks some of the biggest clubs CSO's. Listen to the debate and conversation. And you can answer the questions yourself about the club you would build. See the questions below and send the hosts your thoughts on Bluesky or in the Discord!What are your objectives for the next 1-3-5 years? How are we measuring our targets?What's your thesis on why you will be successful? In 1-2 sentences, tell me why you'll beat out the 29 other people trying to do the same thing as you?What are your Roster Pillars? What are the ~5 things that you need to achieve with your squad to be successful in MLS? (They do not need to be the same for every team.)What are the categories of players within your roster? How are you defining and measuring them?

Contemporary American Composers by CSO Association

It's planners talking brands they've never worked on. I'm joined this month by Kate Rush Sheehy, CSO at GSD&M and Brendon Volpe, CSO at UM NYC. We're talking about the latest work from Burberry and Johnnie Walker. Thanks to Tracksuit and System1 for making this series possible. 

Today's guests are Daniel Lidar, Holder of the Viterbi Professorship of Engineering at USC, Director of the USC Center for Quantum Information Science & Technology, co-founder and CSO of Quantum Elements, Inc., and Izhar Medalsy, Co-founder and CEO of Quantum Elements. Quantum Elements develops tools to reduce noise in quantum computers for scalable performance. Daniel and Izhar join Emerj Editorial Director Matthew DeMello to explore why quantum computing is entering enterprise strategy now, explaining qubits, quantum simulation, and practical applications beyond hype. Daniel and Izhar also share practical takeaways like quantum simulation for accurate materials and drug design, optimization for financial portfolios, post-quantum encryption for data centers, and assessing business impact by identifying problems quantum solves today. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Eugene: Staying focused on a North Star.Eugene Chan, CEO and founder of rHEALTH, has taken blood diagnostics to new heights—literally. His innovative technology, capable of analyzing dozens of biomarkers from a single drop of blood, was tested aboard the International Space Station (ISS). In today's episode, Eugene shared the remarkable journey of rHEALTH, from competing with top companies for a NASA partnership to launching its device into space.What sets rHEALTH apart is its proven reliability in extreme conditions, including the zero-gravity environment of space. Eugene explained, “We tested this technology on the International Space Station with astronaut Samantha Cristoforetti, who operated the device and obtained precise values from single drops of sample. They did the analysis using our device and got absolutely the right answers.” This achievement underlines the robustness and accuracy of rHEALTH's technology, qualities that distinguish it from other attempts at single-drop blood diagnostics.Unlike Theranos, which famously failed to deliver on similar promises, rHEALTH's technology has been rigorously vetted. Eugene highlighted the grueling process of earning NASA's trust. “To be the one company selected to demonstrate our novel technology on the ISS was a huge undertaking,” he said. He recounted the intense competition and NASA's exacting standards, which included testing the device's functionality during zero-gravity parabolic flights.Now, Eugene and his team are bringing this groundbreaking technology to the public with a regulated crowdfunding campaign on StartEngine. “You don't have to be a Silicon Valley elite or a Boston venture capitalist to participate,” I noted during the episode. With this campaign, everyday investors have the opportunity to support a proven technology poised to revolutionize healthcare.The implications of rHEALTH's success are profound. If it works in space, it can work in remote clinics, underserved communities, and even in people's homes. This technology has the potential to make diagnostics more accessible, empowering individuals to take control of their health.Eugene's vision, combined with rHEALTH's proven track record, makes this an exciting investment opportunity. Visit StartEngine to learn more and become part of this revolutionary journey.tl;dr:Eugene Chan shared how rHEALTH's diagnostic technology was tested and proven aboard the International Space Station.He explained the rigorous process of competing with other companies to secure NASA's trust.rHEALTH's crowdfunding campaign on StartEngine makes investing in this revolutionary technology accessible to all.Eugene highlighted the importance of his North Star: improving human health with innovative solutions.He shared advice on maintaining focus and using challenges as opportunities to achieve big goals.How to Develop Staying Focused on a North Star As a SuperpowerEugene's superpower is his ability to maintain a relentless focus on his “North Star”—the overarching goal of improving human health. As he explained, “The North Star has always been to improve the human condition and help us improve human health.” For Eugene, this guiding principle has driven his work through challenges, from competing for NASA's attention to developing groundbreaking diagnostic technology.One illustrative story of this superpower came during a pivotal moment in Eugene's career. While competing in the XPRIZE competition, he found himself grappling with a flawed prototype. It was during this time, sitting at his wife's bedside after the birth of their child, that the concept for rHEALTH's current device was born. Combining the pressure of the competition, the inspiration of his newborn daughter, and his unwavering focus on creating a robust solution, Eugene developed the technology that would later achieve success in space.Eugene also shared actionable tips for developing this superpower:Identify your personal North Star—a goal or mission that deeply resonates with you.Let that North Star guide your decisions, especially during challenging times.Stay committed to your mission, even when facing setbacks or obstacles.Use external pressures, like deadlines or competitions, to fuel innovation and progress.By following Eugene's example and advice, you can make staying focused on a North Star a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileEugene Chan (he/him):CEO, Founder, rHEALTHAbout rHEALTH: rHEALTH has worked with NASA to develop a miniaturized diagnostic test system to keep astronauts healthy on the way to Mars. We have successfully tested this onboard the International Space Station and published the results in Nature Communications, demonstrating results from blood in minutes in extreme environments. The technology shrinks a central clinical lab and a team of doctors in a form suitable for everyday use. Comprehensive lab-quality analysis can be performed by anyone, fundamentally shifting diagnostics from centralized facilities to the point-of-care and homes. The focus is to usher in Diagnostics 2.0, allowing high-value multiplexed diagnostics.Website: rhealth.comOther URL: startengine.com/offering/rhealthBiographical Information: Dr. Chan is a physician-inventor. He is currently Founder, CEO of rHEALTH, and President, CSO of DNA Medicine Institute, a medical innovation laboratory. He has been honored as Esquire magazine's Best and Brightest, one of MIT Technology Review's Top 100 Innovators, and an XPRIZE winner. His work has contributed to the birth of next-generation sequencing, health monitoring in remote environments, and therapeutics. Dr. Chan holds over 60 patents and publications, with work funded by the NIH, NASA, and USAF. Dr. Chan received an A.B. in Biochemical Sciences from Harvard College summa cum laude in 1996, received an M.D. from Harvard Medical School with honors in 2007, and trained in medicine at the Brigham and Women's Hospital. He has been in zero gravity and led the team that demonstrated the rHEALTH ONE bioanalyzer onboard the International Space Station.LinkedIn Profile: linkedin.com/in/eugene-chan-4220045Personal Twitter Handle: @Dr_EugeneChanSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include Crowdfunding Made Simple. Learn more about advertising with us here.Max-Impact Members(We're grateful for every one of these community champions who make this work possible.)Brian Christie, Brainsy | Cameron Neil, Lend For Good | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Justin Starbird, The Aebli Group | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Mike Green, Envirosult | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.SuperGreen Live, January 22–24, 2026, livestreaming globally. Organized by Green2Gold and The Super Crowd, Inc., this three-day event will spotlight the intersection of impact crowdfunding, sustainable innovation, and climate solutions. Featuring expert-led panels, interactive workshops, and live pitch sessions, SuperGreen Live brings together entrepreneurs, investors, policymakers, and activists to explore how capital and climate action can work hand in hand. With global livestreaming, VIP networking opportunities, and exclusive content, this event will empower participants to turn bold ideas into real impact. Don't miss your chance to join tens of thousands of changemakers at the largest virtual sustainability event of the year. Learn more about sponsoring the event here. Interested in speaking? Apply here. Support our work with a tax-deductible donation here.SuperCrowd Impact Member Networking Session: Impact (and, of course, Max-Impact) Members of the SuperCrowd are invited to a private networking session on January 27th at 1:30 PM ET/10:30 AM PT. Mark your calendar. We'll send private emails to Impact Members with registration details.Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Join C-AR Annual Reporting: Requirements, Deadlines, and Lessons Learned from the Field on January 14, 2026, an informative online webinar designed to help crowdfunding issuers and professionals clearly understand C-AR annual reporting requirements, key deadlines, and real-world insights to stay compliant and prepared.Join UGLY TALK: Women Tech Founders in San Francisco on January 29, 2026, an energizing in-person gathering of 100 women founders focused on funding strategies and discovering SuperCrowd as a powerful alternative for raising capital.If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.Manage the volume of emails you receive from us by clicking here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

Great Guest Soloists by CSO Association

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with 20+ CEO/c-suite leaders from the CDMO space, who discuss the optimism levels for the pharmaceutical and biotechnology space for 2026.   Guests include: Christiane Bardroff, Chief Operating Officer (COO) at Rentschler Biopharma SE Philip Macnabb, Chief Executive Officer at Curia Kaan-Fabian Kekec, Partner at Simon-Kucher‘s Healthcare & Life Sciences division Dirk T. Lange , Chief Executive Officer at Pyramid Pharma Services Bruce Thompson, CTO at Kincell Bio Bill Vincent, Biotech Entrepreneur, CEO, Board Member Derek Hennecke - founder, investor, board member Matthew Bio, CSO at Cambrex & President, Snapdragon Chemistry Stephen Dilly, CEO at Sonoma Biotherapeutics, Bill Humphries, Chief Executive Officer at Medpharm Elisabeth Stampa, CEO at Medichem SL Philip Lee, CEO at GeneFab Kerstin Dolph, SVP of Manufacturing at Charles River Labs Eric Edwards, Chief Executive Officer at Phlow-USA Peter DeYoung, CEO at Piramal Pharma Ian Tzeng, Managing Director at L.E.K. Consulting Adam Siebert, Managing Director at L.E.K. Consulting J.D. Mowery, President CDMO Division Bora Pharmaceuticals Peter Belden President, US, Tjoapack   Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

All links and images can be found on CISO Series. Check out this post for the discussion that is the basis of our conversation on this week's episode, co-hosted by me, David Spark, the producer of CISO Series, and Jerich Beason, CISO, WM. Their guest is Pam Lindemoen, CSO and vp of strategy, RH-ISAC. In this episode: From loudest to most trusted Letting go of the win Listening over proving Beyond right and wrong Huge thanks to our sponsor, Alteryx Alteryx is a leading AI and data analytics company that powers actionable insights that help organizations drive smarter, faster decisions. Alteryx One helps security, risk, and operations leaders cut hours of manual work to minutes, generate trusted insights at scale, and turn raw data into action faster than ever. Learn more at www.alteryx.com.  

durée : 00:33:06 - Questions du soir : le débat - par : Quentin Lafay, Stéphanie Villeneuve - Trois cent cinquante tracteurs devant l'Assemblée nationale, fumier et produits alimentaires déversés sur la voie publique : depuis décembre 2025, la colère agricole s'impose par des actions spectaculaires. - invités : Sylvain Brunier Sociologue et historien, chargé de recherche au CNRS et au Centre de sociologie des organisations (CSO), à Sciences Po; Edouard Lynch Professeur d'histoire contemporaine à l'Université Lumière Lyon 2, membre du Laboratoire d'études rurales, spécialiste de l'histoire de la paysannerie française au XXe siècle

⏮️ Il y a deux ans, on enregistrait un premier épisode hors-série avec les fondateurs de Kupp.Le concept était tout neuf, ambitieux, un peu fou aussi : créer un championnat en ligne de CSO, pour redonner du sens à nos saisons de concours.

Thank you to our sponsors, Uniswap and Figure Markets! Amid several years of economic challenges, Venezuela boasts a long and intriguing relationship with crypto. Following the capture of President Nicolas Maduro by the U.S. government, these crypto ties have again been brought into focus. In this Unchained podcast episode, Ledn cofounder Mauricio Di Bartolomeo and Economic Inclusion Group President Jorge Jraissati join Laura Shin to unpack this history, including the plausibility of the Latin American country sitting on a $60 billion Bitcoin stash. Mauricio details how the hums of Bitcoin mining rigs became the sound of freedom for Venezuelans. Jorge says post-Maduro Venezuela will “demand” a crypto powered economy. Will the crypto industry shape the future of Venezuela? And what does such a future look like? Hosts: Laura Shin Guests: Mauricio Di Bartolomeo, Cofounder and CSO of Ledn Jorge Jraissati, President of Economic Inclusion Group Links: Bitcoin Rallies to $93,000 After U.S. Attack on Venezuela How Maduro's Capture and a ‘Pre-War World' Affects Bitcoin: Bits + Bips Brian Kelly on Token-Curated Registries, Robinhood Crypto Trading and the Petro Learn more about your ad choices. Visit megaphone.fm/adchoices

All links and images can be found on CISO Series. This week's episode is hosted by David Spark, producer of CISO Series and Matthew Southworth, CSO, Priceline. Joining them is sponsored guest, Saket Modi, CEO, Safe Security. This episode was recorded live at FAIRCON25 in NYC. In this episode: AI won't stay broken Identity before intelligence People decide risk appetite Automate with oversight Huge thanks to our sponsor, Safe Security SAFE is the leader in Cyber Risk Quantification and the first company to deliver 100% autonomous Third-Party Risk Management. Powered by Agentic AI and built on FAIRtm, SAFE empowers CISOs, cybersecurity, and TPRM leaders to continuously quantify, prioritize, and mitigate cyber risks across their entire attack surface – enabling digital growth and organizational resilience. Learn more at testdrive.safe.security/

Canellakis & Gerstein by CSO Association

Ryan Rogers and Coby McDougal, CEO and CSO, respectively, with Yates Flooring Center, and Kemp Harr discuss Yates' year end success and highlights of the Dallas regional flooring show. Listen to the interview for more details.

The Transformation Ground Control podcast covers a number of topics important to digital and business transformation. This episode covers the following topics and interviews:   IT's Having Its Best Year Since 1996, Q&A (Darian Chwialkowski, Third Stage Consulting) The 2025 ERP Awards (Greg Benton, CSO at Third Stage Consulting) How Your ERP System Is Making You Weaker We also cover a number of other relevant topics related to digital and business transformation throughout the show.  

A Chicago Symphony Chorus Spotlight by CSO Association

In the digital era, cybersecurity plays a critical role in business, especially banking, as transactions, data, and customer interactions increasingly rely on technology. Beyond protecting financial and personal information from growing cyber threats, cybersecurity teams help build secure yet seamless systems that enable smooth transactions and support long-term customer trust.When implemented effectively, cybersecurity moves beyond being a passive defense function and becomes a strategic enabler, helping banks improve customer experience and maintain competitiveness in a digital-first environment.To explore this role further, Vietnam Innovators Podcast – Episode 371 features a conversation with Sandro Bucchianeri, Group Chief Security Officer at NAB.With more than 25 years of experience in cybersecurity, including 15 years in executive leadership roles such as CISO and CSO, Sandro has worked with multinational organizations, led global teams, and delivered large-scale strategic transformation programs. Combining deep expertise in risk management, security, and legal frameworks with an innovative mindset, he shares a clear and practical perspective on why cybersecurity matters—not only for organizations, but also for customer trust and experience in the digital age.Listen to this episode on YouTubeAnd explore many amazing articles about the pioneers at: https://vietcetera.com/vn/bo-suu-tap/vietnam-innovatorFeel free to leave any questions or invitations for business cooperation at hello@vni-digest.com

Pawan Joshi, CSO at supply chain platform e2open, joins Lisa Dent on the show to talk about how uncertainty could be the headline of the holiday season and carry over well into the new year with regards to tariffs.

Handel Messiah & Tchaikovsky Nutcracker by CSO Association

In this follow-up to Part 1, we continue our conversation with Ryosuke (Ryo) Murai, CEO and co-founder of AI Market and former CSO of Connected Robotics, where he led a ¥1.7B Series B raise.This episode is all about how to stand out as a potential co-founder, what really matters during the decision-making process, and how to build a founding team that can last, especially in the Japan startup ecosystem.Ryo shares his perspective on the co-founder "dating process," how to assess fit beyond just skills, and why 3 co-founders ended up being the right structure for their team.If you're thinking about starting a company in Japan, or advising someone who is, this is an honest and practical look at how co-founder partnerships are actually formed.What you'll learn in this episode:What founders look for when choosing a co-founderHow to communicate your vision without overhypingWhy startup experience isn't everything (and what matters more)The emotional and mindset fit behind great co-founder teamsWhy AI Market chose to bring on a third co-founderShow Notes:00:00 – Introduction and recap from Part 101:34 – What makes someone stand out as a co-founder04:50 – Selling your vision and framing your skills09:00 – Is track record necessary? What else matters?14:05 – Dating analogy continued: chemistry and red flags19:50 – Co-founder role clarity and team structure23:40 – Why 3 co-founders worked better than 228:12 – Final thoughts for founders entering the co-founder searchGuest:Ryosuke (Ryo) Murai – CEO & Co-founder, AI MarketLinkedIn: https://www.linkedin.com/in/ryosukemurai/

Planning's greatest Holiday Ads Party returned live to the Merchandise Mart in Chicago. A packed house watched and debated some of the best holiday ads from the US and UK. On stage were Nimisha Jain, CSO at Highdive, Pedr Howard, Head of Creative Excellence at Ipsos, Samantha Cescau, CSO at Leo Burnett and Mark Gross, Co-Founder and Co-CCO at Highdive. Love to hear what your favorite Holiday spot was this year. Thanks to Ipsos, The Effies and Tracksuit for supporting our 2025 live tour. Happy Holidays everyone.

In this episode, host Kim Jones tacks a topic that is rapidly moving from theoretical to operational reality: quantum computing. While classical computing will remain the backbone of our systems for years to come, quantum technologies are advancing fast enough that CISOs must begin preparing today. Kim explores what quantum computing really means, why it matters for cybersecurity, and how leaders should begin planning for its inevitable impact. To help demystify the subject, Kim is joined by longtime colleague and cybersecurity practitioner Michael Sottile—now the CSO of a quantum computing firm—who brings decades of hands-on experience across industries and a front-row seat to quantum's evolution. Want more CISO Perspectives? Check out a companion ⁠⁠blog post⁠⁠ by our very own Ethan Cook, where he breaks down key insights, shares behind-the-scenes context, and highlights research that complements this episode. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mahler Festival Broadcast: Mahler 7 by CSO Association

In this episode of The Gate 15 Interview, Andy Jabbour speaks with leaders from the Information Sharing and Analysis Center (ISAC) community on the Cybersecurity Information Sharing Act, the government shutdown, the role and future of ISACs and what to look forward to in 2026. Experts include:Errol Weiss, CSO, Health-ISACAdam Gruszcynski, IT Director at Potawatomi Casino Hotel & Tribal-ISAC Steering Committee MemberKimberly Denbow, Vice President, Security and Operations, AGA & Executive Director, DNG-ISACChris Anderson, Principal Advisor, National Security and Emergency Preparedness at LumenIn the discussion the panel covers:The Cybersecurity Information Sharing Act of 2015 (CISA 2015), it's recent and potential lapse and how it impacted cyber threat information sharing and collaboration.The recent and potentially upcoming federal government shutdown and how the ISACs operated and were impacted.From the TribalNet Cybersecurity Summit to the Natural Gas Exercise 2026 (NGX-2026), operationalizing AI, and growing critical global partnerships – the group discusses some of the many things that they're excited about heading into 2026.Plus! The team plays one question! Warren G: Regulators! And more!Selected links:Health-ISACTribal-ISACDNG-ISACCongress extends CISA 2015, but path to long-term reauthorization remains murky

All links and images can be found on CISO Series. Check out this post by Nick Nolen of Redpoint Cyber for the discussion that is the basis of our conversation on this week's episode co-hosted by me, David Spark, the producer of CISO Series, and Geoff Belknap. Joining us is Erika Dean, former CSO, Robinhood. In this episode: Delegation requires accountability The reality of daily decision-making The gap between theory and practice Beyond the advisory role Huge thanks to our sponsor, ThreatLocker ThreatLocker makes Zero Trust practical. With Default Deny, Ringfencing, and Elevation Control, CISOs get real control that's easy to manage and built to scale. Stop threats before they execute and reduce operational noise without adding complexity. See how simple prevention can be at ThreatLocker.com/CISO

What if protein degradation could address neurodegenerative diseases, not just cancer? In this episode, Dr. Angela Cacace, CSO at Arvinas, speaks with Dr. Talar Hopyan, Global Head of CST at Syneos Health, about how the company is advancing a degrader targeting LRRK2 in Parkinson's disease and why early-stage signals in healthy volunteers are raising new possibilities for CNS care. They discuss how Arvinas is engineering blood-brain barrier-penetrant molecules, the translational challenges in neurodegeneration and what's required to move from platform to patient. What you'll learn: How Arvinas is expanding targeted protein degradation into neurology Why LRRK2 degradation is a promising approach for Parkinson's disease What it takes to translate platform innovation into measurable clinical outcomes The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

We are joined by two leaders from Aminex Therapeutics, Mark Burns, President & CSO, and Jeff Judson, VP of Strategic Planning & Investor Relations, to discuss the groundbreaking development of Aminex 1501, a novel cancer therapy that is transforming oncology. This conversation dives into the science behind this innovative therapy, its distinctive funding journey, the promising clinical trial results, and the collaboration with CTI. Listen now to explore the significance of FDA orphan drug designation and what it means for advancing innovative treatments for rare cancers. 00:10 Aminex 1501 is introduced, along with its mission to fight cancer by removing essential growth factors from tumors, stimulating the immune system 00:43 The drug's effectiveness across a wide range of solid tumors, showcasing its tumor-agnostic approach 01:11 Mark shares the origin of Aminex, highlighting its unique funding by angel investors outside biotech and the absence of venture capital 02:01 Why they chose CTI as a partner: technical competence, responsiveness, and Midwest values 03:18 How the therapy removes polyamines from tumors, leading to profound immune responses in animal models 04:11 The team discusses receiving FDA orphan drug designation for neuroblastoma and ongoing pediatric trials at Penn State University 05:15 Insights into the treatment of six rare childhood cancers, with a focus on improving quality of life and minimizing side effects 05:56 Breast cancer and melanoma identified as promising indications for future focus, with neuroblastoma and others also in scope 06:23 Recap of clinical trial progress and milestones  07:19 Recognition of patients as heroes in advancing cancer therapeutics 08:03 How the therapy trains the immune system to recognize and attack cancer 08:57 The inspiration behind targeting polyamines and the development of DFMO and Aminex 1501 10:00 Anecdotes about early animal studies, dramatic tumor shrinkage, and the motivation to continue research 12:13 The team's passion for improving patient outcomes and the importance of collaboration 13:00 Information for patients interested in joining trials, with details on upcoming clinics and how to find more information on clinicaltrials.gov 

Michael Sena is the CSO and Co-Founder of Recall, a decentralized skill market for AI where communities fund, rank, and discover the AI solutions they need. Michael started in crypto in 2016, helped scale ConsenSys from 30 to 1,800 people, co-founded uPort, the first decentralized identity protocol, and 3Box Labs where he led development of Ceramic Network. At Recall, Michael focuses on growing the world's largest AI competitions and giving the community the power to shape and accelerate the future of AI. In this conversation, we discuss:- Google Gemini is elite - Present day AI - The best AI managed crypto strategies are private - How AI-driven reputation systems are reshaping crypto investing - What AI Agent trading competitions mean for the future of AI managed crypto strategies - How open arenas bring trust to AI selection - Why today's AI benchmarks are failing and how decentralized validation could restore trust - Importance of making AI results visible onchain - How Recall is shaping AI discovery, validation, and adoption - Prediction Markets - Their recent NFL Prediction Arena on Thanksgiving and upcoming ones - How AI will impact crypto trading in 2026 RecallX: @recallnetWebsite: recall.networkDiscord: discord.gg/recallnetMichael SenaX: @dataliquidityLinkedIn: Michael Sena ---------------------------------------------------------------------------------This episode is brought to you by PrimeXBT.PrimeXBT offers a robust trading system for both beginners and professional traders that demand highly reliable market data and performance. Traders of all experience levels can easily design and customize layouts and widgets to best fit their trading style. PrimeXBT is always offering innovative products and professional trading conditions to all customers.  PrimeXBT is running an exclusive promotion for listeners of the podcast. After making your first deposit, 50% of that first deposit will be credited to your account as a bonus that can be used as additional collateral to open positions. Code: CRYPTONEWS50 This promotion is available for a month after activation. Click the link below: PrimeXBT x CRYPTONEWS50FollowApple PodcastsSpotifyAmazon MusicRSS FeedSee All

Today's guest is Michael Drexler, Chief Strategy Officer at Brightstar Capital Partners, a private equity firm that invests in closely held, middle-market businesses and helps them scale into professional, process-driven organizations.Michael's career spans leadership roles across investment banking, global strategy, and private equity—from Barclays to the World Economic Forum, and Brightstar Capital Partners—giving him a rare perspective on how strategy functions evolve as companies mature from founder-led to institutional scale. In this conversation, we unpack lessons from Michael's career leading strategy functions  and explore how the head of strategy role transforms along a company's growth journey. Things we will cover: How strategy evolves from a “chief of staff” role in founder-led companies to a full-fledged internal consulting function The mindset shift from advising a single CEO to influencing a broader leadership team How to build and sustain an effective strategy team—including Michael's “2-to-4-year rotation” and “no bad news for two weeks” rules Why private equity firms view internal strategy functions differently—and how to reposition your team in a PE environment Michael's four-step framework for prioritizing projects that's “never failed him once” From developing consulting-style skillsets inside corporations to balancing neutrality among competing executives, Michael brings clarity and practicality to what it means to be an effective CSO. Learn more about Outthinker's community of chief strategy officers - https://outthinker.com/ Follow us on LinkedIn - https://www.linkedin.com/company/outthinker-networks

In this episode of the Scaling Japan Podcast, we're joined by Ryosuke (Ryo) Murai, CEO and co-founder of AI Market and former CSO of Connected Robotics, where he led a ¥1.7B Series B raise. Ryo shares what it actually takes to find a strong co-founder in Japan and opens up about how he and Tyson teamed up to start AI Market.This is Part 1 of a two-part conversation where we dive deep into co-founder decision-making, mindset alignment, storytelling, and early fundraising strategy in Japan.If you're planning to launch a startup in Japan or are in the early stages of finding a co-founder, this episode is packed with practical insights from two operators who have done it.What you'll learn in this episode:Why Ryo decided not to launch soloWhat makes someone an attractive co-founderHow to sell your startup vision to a potential co-founderWhere to actually meet co-founders in JapanThe importance of founder-market fit and track recordWhy AI Market chose to bootstrap with angels instead of raising VCShow Notes00:00 – Introduction02:27 – Why Ryo decided to look for a co-founder04:08 – How Ryo and Tyson met and decided to team up06:52 – What makes an attractive co-founder13:58 – Selling your vision and founder-market fit27:40 – Co-founder fit is like dating30:03 – Where to find co-founders in Japan35:04 – The Benefits of Having Three Co-Founders 38:00 – External Resources: Accelerators and LinkedIn 41:40 – Why AI Market didn't raise VC and chose angel funding45:20 – Alternative Funding Strategy with Angel Investors Stay tuned for Part 2! Links from Guest Appearance:

Por fin en español, El almanaque del pobre Charlie (Valor Editions, 2025) recopila once charlas y discursos de Charles T. Munger (1924-2023), vicepresidente de Berkshire Hathaway y socio y amigo de Warren Buffett. A lo largo de esta sesión repasaremos con Javier González Recuenco la particular idiosincrasia de este excepcional inversor y la importancia del pensamiento multidisciplinar para la toma de decisiones en ámbitos como los negocios y las finanzas. Javier González Recuenco es CSO de Singular Solving y Singular Targeting. Experto en personalización aplicada, ha creado cinco startups. Ha sido CTO en Netdecisions y Ecuality. Es consultor internacional para EY y SchlumbergerSema. Es coautor, junto con Guillermo de Haro, de El pequeño libro de la filosofía estoica (Alienta, 2022).

Solti Conducts Del Tredici by CSO Association

We're joined by Helene Dick, Head of Strategy at Special LA and Tom Kenny, CSO at Courage in Toronto. We discuss new work from The Ordinary and Mother's campaign for Claude AI. Thanks to Tracksuit and System1 for supporting this series.

Mauricio Di Bartolomeo is the co-founder and CSO of Ledn, a leading provider of bitcoin-backed loans. He found Bitcoin during hyperinflation in Venezuela and believes in the future of the digital economy. He has an MBA from the Richard Ivey business school at Western University.Mauricio Di Bartolomeo, the co-founder and CSO of Ledn, recently joined the Bitcoin.com News Podcast to talk about the market.Growing up in Venezuela and experiencing hyperinflation, bank collapses, and capital controls firsthand, Mauricio witnessed the disastrous consequences of a failing government and currency. His family eventually found a solution and "a beam of light" in Bitcoin mining, which allowed his brother to escape the country with his wealth intact on a hardware wallet, an experience that cemented their conviction in Bitcoin as a tool for economic freedom and survival.Mauricio explains how this experience led to the founding of Ledn, a company built to solve the problem faced by Bitcoin miners and holders: the need for financing without having to sell their Bitcoin. He delves into the core value proposition of Bitcoin-backed loans, especially for the emerging world, highlighting that Ledn offers the same rates and terms to clients in Latin America as those in Europe or North America. This capability is providing financial inclusion, giving many in the region their first-ever loan approval, which is a massive, transformative opportunity that traditional banks have historically denied.The discussion pivots to Ledn's decision to transition to a Bitcoin-only company after a period of supporting Ethereum during the Celsius bankruptcy transition. Mauricio outlines the move as a commitment to simplicity and transparency, emphasizing the company's deep belief in the long-term viability and investment case of Bitcoin. The conviction is rooted in the belief that the future of Bitcoin-backed loans is a multi-trillion-dollar opportunity, and Ledn aims to win by focusing on doing Bitcoin-backed loans better than anyone else, adhering to the principle that "the best restaurants have the smallest menus."A crucial component of Ledn's commitment to transparency is its pioneering and ongoing Proof of Reserves protocol. Mauricio details this process, explaining that an independent CPA verifies Ledn holds all the assets it owes its clients by looking at both the asset and liability sides every six months, a cadence the company is moving to monthly. He stresses the vital importance of Proof of Reserves—something all failed crypto lenders like FTX lacked—as a requirement clients should demand, ensuring a company is honestly reporting its liabilities and protecting client assets.The episode also covers the concept of the "new carry trade," which is the strategy of borrowing a weak, constantly-debased currency (like the US Dollar) against a hard, appreciating asset with a finite supply (Bitcoin). Mauricio illustrates this with a client anecdote who was able to buy a house without selling his Bitcoin, which then appreciated fivefold. He explains that this strategy is tax-beneficial and mirrors how the world's wealthy manage their assets, allowing Bitcoin holders to "go short weak dollars and maintain your strong Bitcoin," ultimately helping them grow their net wealth over time.Finally, Mauricio addresses the looming entry of traditional banks into the Bitcoin services space. He argues that Bitcoin-native companies like Ledn have a massive advantage because the banks' fractional reserve model is incompatible with Bitcoin's ethos of full reserves. He cautions users to be skeptical of banks' intentions and collateral practices. Ledn, a regulated business built to operate 24/7 in the volatile crypto market, is focused on building a "Fort Knox" that is designed to outlive its founders and their children, a powerful statement on their commitment to generational wealth and long-term security.To learn more about the company visit Ledn.io, and follow the team on X.

Rakitina, Weilerstein & Tchaikovsky by CSO Association

In this episode of Pharmacy Innovators, host Jim Jorgenson sits down with Jim Jacobsohn, Chief Growth Officer at Visante, and Joelle Hall, Director of Infusion Strategy, to explore how infusion services are becoming a strategic lever for hospitals and health systems. The conversation highlights how shifting care delivery models, increasing consumer expectations, payer pressures, and new market disruptors are reshaping infusion strategy—requiring health systems to rethink how and where care is delivered across hospital outpatient, AIS, and home infusion settings. The guests discuss why pharmacy is uniquely positioned to lead this transformation and how connecting infusion services to enterprise strategy can drive improved access, financial sustainability, and better patient and provider experiences. They outline critical success components—including footprint design, payer contracting, revenue cycle alignment, analytics, and patient experience—and offer insights on partnership models and return-on-investment expectations. Whether you're a CPO, CSO, CFO, or health system strategist, this episode provides a practical and forward-looking view of the infusion landscape and how to compete in a rapidly evolving market.

What does strategy really look like inside a construction firm that wants to grow on purpose, not by accident? In this episode of the PSM Show, host Damion Morris talks with James Hatch, Chief Strategy Officer at Kovac Building Enclosures, one of the top glazing contractors in the country. James shares how his path through architecture, estimating, finance, and business development shaped the way he leads strategy today – and why he sees the CSO as the "agent of change" inside the firm. They dig into what it takes to keep the "periscope above the water," choose the right pursuits, and build a culture that supports change instead of resisting it. Along the way, James talks candidly about Kovac's shift from private equity to employee ownership, why authenticity matters more than polish, and what emerging leaders should practice now if they are drawn to the work of strategy.

In this episode of TechMagic, hosts Cathy Hackl and Lee Kebler break down the biggest shifts shaping tech, entertainment, and personal branding. They explore emerging trends, from real-world experiences like Beastland, to the growing influence of spatial computing, and why authentic human content is becoming a premium as AI saturation rises. In the second half, Cathy sits down with David Cash, Founder and CSO of Cash Labs, Founder and Executive Producer of Catalyst Content Haus and Head of Marketing and acting CMO of DeLorean Labs, to discuss building a future-proof personal brand, repurposing content at scale, and why founders must take ownership of their digital presence now. Together, they reveal practical strategies for standing out and earning trust in an AI-driven media landscape.Come for the tech and stay for the magic!David Cash Bio:David Cash is the Founder of Cash Labs and Catalyst, recognized as a leading force in bringing Web3 and emerging technologies to market. After a 12-year acting career and seven years running a production company, working on campaigns for brands like Brisk, Gaviscon, and Netflix, David became an early leader in Web3, authoring the first Master's thesis on NFTs and producing Metaverse Fashion Week. Through Cash Labs, his work has driven billions of impressions and major revenue for global brands. His newest venture, Catalyst, helps executives create high-impact, future-ready content.David Cash on LinkedInKey Discussion Topics: 00:00 Intro: Tech Magic Returns from the Middle East00:03 Beastland: MrBeast's Pop-Up Amusement Park Phenomenon in Riyadh00:08 Apple Vision Pro & Real Madrid: The Future of Immersive Sports Content00:12 Tim Cook's Potential Departure and Apple's Need for Disruption00:16 Meta Quest 3S at Costco for $200: The VR Hardware Game Heats Up00:20 Meet David Cash: From Child Actor to Web3 Pioneer and Content Strategist00:24 Why Business Leaders Must Own Their Content Strategy Now00:27 Catalyst: Productizing Executive Content Creation Into a Luxury Service00:30 How to Build a Personal Brand Session in One Day00:33 The Dead Internet Theory: Why Authentic Voices Are Your Competitive Moat00:36 Syndication Strategy: Turn One Piece of Content Into 1,000 Assets00:37 Legacy Media Still Matters: Why Adweek and Vogue Amplify Personal Brands00:40 The Evolution of Entertainment: From Broadway to Authentic Vlogging00:43 Human-Crafted Content as Luxury: The OnlyFans to OnlyWalks Future00:44 The Metaverse Isn't Web3: Redefining Virtual Spaces and Digital Identity00:48 How Your Content Choices Today Shape Your XR Future Tomorrow00:52 AI as a Tool: When to Use Generative Tech and When to Create Authentically00:53 The "Human Authored" Label: Why AI Slop Is Making Credibility Scarce00:57 Silicon Valley's Billion-Dollar Paradox: Oracle, SoftBank, and Unsustainable Bets01:00 Hardware Matters: Why Lam Research Is the Invisible Infrastructure Winner01:03 Key Takeaways: Personal Branding, Content Strategy, and the Human Edge Hosted on Acast. See acast.com/privacy for more information.

Subscribe to the Blockspace newsletter for market-making news as it hits the wire! Welcome back to The Mining Pod! Today, Haris Basit, CSO at Bitdeer, joins us to break down their Q3 results, where revenue hit $169.7M (up 173% YoY), self-mining production doubled to 1,109 BTC, and they achieved 41.2 EH/s of self-mining capacity. We dive deep into Bitdeer's AI and HPC expansion strategy across sites in Norway, Tennessee, Washington, and Ohio, discuss the SEALMINER A3's production schedule and A4 chip development delays, and get updates on the Massillon facility fire recovery. Subscribe to the newsletter! https://newsletter.blockspacemedia.com **Notes:** • Revenue up 173% YoY to $169.7M • Self-mining doubled: 565 to 1,109 BTC • Hash rate reached 41.2 exahash in October • Adjusted EBITDA: $43M vs -$7.9M last year • SEALMINER delays • AI expansion: planned across 4 sites Timestamps: 00:00 Start 03:32 Overview of report 05:43 Colocation vs self mining vs neoloud 09:30 Why do both colocation & neocloud? 10:42 Facility fire 12:13 Bhutan 15:01 Convertible notes 16:43 Future financing options 18:54 Cloud mining profitability 19:57 Choosing where to locate services 22:11 Alberta 24:03 Ethiopia 25:20 ASIC production 28:35 A4 delays 31:39 What's coming?

Financial data has its challenges—but non-financial data is a different scale of complexity. It cuts vertically up and down the value chain, and now requires the same level of confidence as financials, with board sign-off and external assurance becoming the norm. In this episode of The Pre-Read, we break down how finance and sustainability leaders are aligning around programs like sustainability-linked bonds, why a long-term mindset matters, and how AI is helping organizations make sense of fragmented, non-standardized information. 
 • Why sustainability data is more complex than financial data • The need for integration—top-down from the board and across every business unit • How companies build data confidence through external assurance • The two-pillar reporting model: impact (GRI, SDGs) and value (ISSB, TCFD, TNFD) • Why brave leadership and a growth mindset are essential for adopting new technology Featuring: Esther An, CSO, City Developments Limited Andrea Amozurrutia Casillas, Finance and Sustainability Director, Grupo Herdez Read the full report on how professionals are building value with AI: workiva.com/pr-building-value Key Segments: 01:00 | Why sustainability data is more complex 03:50 | The two-pillar approach: Impact + value 08:30 | Esther An on board sign-off and assurance 15:30 | Long-term view in a volatile environment 18:00 | Andrea Amozurrutia Casillas on sustainability-linked bonds 25:30 | Why AI matters for data chaos Find more conversations at workiva.com/podcast/the-pre-read Subscribe for upcoming episodes.

Patch Tuesday. Google sues a “phishing-as-a-service” network linked to global SMS scams, and launches “private ai compute.” Hyundai notifies vehicle owners of a data breach.  Amazon launches a bug bounty program for its AI models. The Rhadamanthys infostealer operation has been disrupted. An initial access broker is set to plead guilty in U.S. federal court. Our guest is Bob Maley, CSO from Black Kite, discussing a new AI assessment framework. “Bitcoin Queen's” $7.3 billion crypto laundering empire collapses. Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. CyberWire Guest On our Industry Voices segment, we are joined by Bob Maley, CSO from Black Kite, discussing a new AI assessment framework. You can hear Bob's full conversation here. Selected Reading Microsoft Fixes Windows Kernel Zero Day in November Patch Tuesday (Infosecurity Magazine) Chipmaker Patch Tuesday: Over 60 Vulnerabilities Patched by Intel (SecurityWeek) ICS Patch Tuesday: Vulnerabilities Addressed by Siemens, Rockwell, Aveva, Schneider (SecurityWeek) Adobe Patches 29 Vulnerabilities (SecurityWeek) High-Severity Vulnerabilities Patched by Ivanti and Zoom (SecurityWeek) Google launches a lawsuit targeting text message scammers (NPR) Private AI Compute: our next step in building private and helpful AI (Google) Hyundai confirms security breach after hackers access sensitive data (CBT News) Amazon rolls out AI bug bounty program (CyberScoop) Rhadamanthys infostealer disrupted as cybercriminals lose server access (Bleeping Computer) Russian hacker admits helping Yanluowang ransomware infect companies (Bitdefender) $7.3B crypto laundering: ‘Bitcoin Queen' sentenced to 11 Years in UK (Security Affairs) Share your feedback. What do you think about CyberWire Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show. Want to hear your company in the show? N2K CyberWire helps you reach the industry's most influential leaders and operators, while building visibility, authority, and connectivity across the cybersecurity community. Learn more at sponsor.thecyberwire.com. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

All links and images can be found on CISO Series. This week's episode is hosted by David Spark, producer of CISO Series and Jeff Steadman, deputy CISO, Corning Incorporated. Joining them is Quincey Collins, CSO, Sheppard Mullin. This episode was recorded live at the ISSA LA Summit in Santa Monica, California. In this episode:  The foundational debate Strength over breadth Beyond traditional backgrounds Keeping perspective on risk Huge thanks to our sponsors, Adaptive Security and Dropzone AI AI-powered social engineering threats like deepfake voice calls, GenAI phishing, and vishing attacks are evolving fast. Adaptive helps security leaders get ahead with an AI-native platform that simulates realistic genAI attacks, and delivers expert-vetted security awareness training — all in one unified solution. Learn more at adaptivesecurity.com. Dropzone AI autonomously investigates every security alert—no playbooks needed. This AI SOC analyst queries your CrowdStrike, Splunk, threat intel feeds, and 60+ other tools to build complete investigations in 5 minutes. Unlike black-box automation, it shows every query, finding, and decision. See it work yourself—explore the self-guided demo at dropzone.ai.

 This is an update for proposed episodes in 2026, and a discussion about the future of the show, or if it even has a future. The post CSO 2026 Plans and Other Matters first appeared on Cinema Story Origins Podcast.